Investments
313Portfolio Exits
107Funds
1About Investor Growth Capital
Investor Growth Capital is the wholly owned venture capital arm of Investor AB (Investor). Investor, publicly traded on the Stockholm exchange, is the largest listed industrial holding company in Northern Europe. Investor was founded in 1916 by the Wallenberg family.
Investor Growth Capital Headquarter Location
Arsenalsgatan 8C
Stockholm, SE-103 32,
Sweden
+46 8 614 20 00
Latest Investor Growth Capital News
Jan 8, 2018
Intuity Medical, Inc. , a Fremont, Calif.-based company developing innovative technologies for diabetes management, closed $42.5M in the initial tranche of a $70M total round of funding. This included: – $40M in equity financing from existing investors Accuitive Medical Ventures, Investor Growth Capital, KCK Group, affiliates of Luther King Capital Management, PTV Healthcare Capital, U.S. Venture Partners and Versant Ventures, plus – $30M in debt financing from Hercules Capital. The company intends to use the funds to strengthen its financial position to commercialize POGO and Patterns in the U.S. Led by Emory Anderson, President and CEO, Intuity is advancing the POGO® Automatic™ Blood Glucose Monitoring System , a blood glucose meter and multi-test cartridge that provides automatic testing with lancing, blood collection and analysis without the need for separate strips and lancets. By combining all of the necessary blood glucose testing supplies into a self-contained 10-test cartridge, POGO provides a discreet solution for patients who need to regularly test their blood glucose in the management of their diabetes. To perform a test, a patient simply presses the POGO test port, and POGO automatically lances the finger, collects a blood sample and displays a result after a four-second countdown. The test only requires a tiny blood sample of 0.25 microliters to analyze the glucose value. After completing 10 tests, the self-contained cartridge can be conveniently disposed of, eliminating the need to handle used test strips and lancets. When combined with the company’s proprietary Patterns® Diabetes Management System, a secure cloud-based platform for managing glucose information, POGO provides both healthcare professionals and patients a comprehensive shared platform to detect and manage important patterns and trends that impact overall glucose control. The system has already received clearance from the U.S. Food and Drug Administration (FDA). FinSMEs 08/01/2018
Investor Growth Capital Investments
313 Investments
Investor Growth Capital has made 313 investments. Their latest investment was in ReviewTrackers as part of their Series B on June 6, 2019.
Investor Growth Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/25/2019 | Series B | ReviewTrackers | $10M | Yes | 7 | |
1/8/2018 | Series H | Intuity Medical | $40M | No | 4 | |
6/6/2017 | Series G | Neuronetics | $15M | No | 3 | |
1/5/2017 | Series G - II | |||||
11/10/2016 | Series G |
Date | 6/25/2019 | 1/8/2018 | 6/6/2017 | 1/5/2017 | 11/10/2016 |
---|---|---|---|---|---|
Round | Series B | Series H | Series G | Series G - II | Series G |
Company | ReviewTrackers | Intuity Medical | Neuronetics | ||
Amount | $10M | $40M | $15M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 7 | 4 | 3 |
Investor Growth Capital Portfolio Exits
107 Portfolio Exits
Investor Growth Capital has 107 portfolio exits. Their latest portfolio exit was ReviewTrackers on June 16, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
6/16/2022 | Acquired | 1 | |||
4/29/2021 | Acquired | 3 | |||
10/8/2020 | Acquired | 3 | |||
Date | 6/16/2022 | 4/29/2021 | 10/8/2020 | ||
---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 | 3 | 3 |
Investor Growth Capital Acquisitions
5 Acquisitions
Investor Growth Capital acquired 5 companies. Their latest acquisition was EBH Finansservice on September 27, 2010.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
9/27/2010 | Acq - Fin | 1 | ||||
1/28/2008 | ||||||
6/22/2006 | ||||||
4/10/2006 | ||||||
3/18/2004 |
Date | 9/27/2010 | 1/28/2008 | 6/22/2006 | 4/10/2006 | 3/18/2004 |
---|---|---|---|---|---|
Investment Stage | |||||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acq - Fin | ||||
Sources | 1 |
Investor Growth Capital Fund History
1 Fund History
Investor Growth Capital has 1 fund, including IGC Fund VI.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
9/28/2011 | IGC Fund VI | Diversified Private Equity | Open | $1,300M | 1 |
Closing Date | 9/28/2011 |
---|---|
Fund | IGC Fund VI |
Fund Type | Diversified Private Equity |
Status | Open |
Amount | $1,300M |
Sources | 1 |
Investor Growth Capital Team
31 Team Members
Investor Growth Capital has 31 team members, including current Chief Executive Officer, President, Borje Ekholm.
Name | Work History | Title | Status |
---|---|---|---|
Borje Ekholm | Chief Executive Officer, President | Current | |
Karl Swartling | Chief Executive Officer, Managing Director | Current | |
Lennart Johansson | Chief Financial Officer | Current | |
Guarav Aggarwal | Managing Director | Current | |
Hakan Jansson | Managing Director | Current |
Name | Borje Ekholm | Karl Swartling | Lennart Johansson | Guarav Aggarwal | Hakan Jansson |
---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer, President | Chief Executive Officer, Managing Director | Chief Financial Officer | Managing Director | Managing Director |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.